Displaying 1 - 1 of 1
| Active Ingredient | EFAVIRENZ | EMTRICITABINE | TENOFOVIR |
| Therapeutic Class | ANTIRETROVIRALS MISCELLANEOUS |
| Indications | HIV infection |
| Caution | Lactic acidosis and severe hep atomegaly with steatosis, including fatal cases, have been rep orted with the use of nucleoside analogues in combination with other antiretrovirals. |
| Dose Range | One tablet once daily on an empty stomach; not recommended for pediatric patients younger than 18 years. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |